---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-231167"
form_type: "8-K"
ticker: "CLYM"
cik: "0001768446"
company_name: "Climb Bio, Inc."
filed_at: "2024-10-02T23:59:59+00:00"
generated_at: "2026-05-30T22:42:41.247665+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Eliem Therapeutics renames to Climb Bio, ticker changes to CLYM on Nasdaq

## Summary
- Name change from Eliem Therapeutics, Inc. to Climb Bio, Inc. effective October 2, 2024.
- New trading symbol CLYM on Nasdaq Global Market starts October 3, 2024.
- CUSIP number for common stock remains unchanged; stockholder rights unaffected.
- Certificate of incorporation amended solely for name; bylaws conformed to new name.

## SEC filing metadata
- accession: 0001193125-24-231167
- form_type: 8-K
- ticker: CLYM
- cik: 0001768446
- company_name: Climb Bio, Inc.
- filed_at: 2024-10-02T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1768446/000119312524231167/0001193125-24-231167-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1768446/000119312524231167/d888487d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-231167
- JSON: https://secwatch.observer/filing/0001193125-24-231167.json
- Plain text: https://secwatch.observer/filing/0001193125-24-231167.txt

## Key facts
- Governance Changes
  Climb Bio, Inc.: Amended and restated bylaws solely to reflect the name change (effective 2024-10-02).
  - Change: bylaw amendment
  - Effective: 2024-10-02
  source text: the Board also approved an amendment and restatement of the Company’s Amended and Restated Bylaws solely to reflect the Name Change (as amended and restated, the “Amended and Restated Bylaws”) effective as of October 2, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1768446/000119312524231167/0001193125-24-231167-index.htm
- Governance Changes
  Climb Bio, Inc.: Amended certificate of incorporation to change company name from Eliem Therapeutics, Inc. to Climb Bio, Inc (effective 2024-10-02).
  - Change: charter amendment
  - Effective: 2024-10-02
  source text: Effective as of 4:00 p.m., Eastern Time on October 2, 2024, Eliem Therapeutics, Inc. (the “Company”) amended its Amended and Restated Certificate of Incorporation (the “Certificate of Incorporation”), to effect a change of the Company’s name from “Eliem Therapeutics, Inc.” to “Climb Bio, Inc.”
  evidence_url: https://www.sec.gov/Archives/edgar/data/1768446/000119312524231167/0001193125-24-231167-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.